// Investor Relations
Investing in
Akouō Health
Akouō Health is building a new signal intelligence layer for healthcare — combining voice and physiological data to detect early change across conditions.
As care shifts beyond the clinic, clinicians lack continuous visibility into patient status between visits.
Request Investor Materials
// Key Highlights
A new category of clinical intelligence platform.
◆
A new class of platform unifying voice and vital signs into a continuous signal intelligence layer for healthcare.
◆
Early clinical validation across multiple countries, with active engagements at leading academic medical centers.
◆
Initial focus: early identification of patient deterioration between visits and after discharge — particularly in outpatient and continuous (longitudinal) care settings.
◆
Designed for scalable deployment in outpatient and remote care settings — no new hardware, no workflow disruption
// Clinical Evidence
Early clinical evaluation demonstrated high sensitivity (98%) for identifying patients with confirmed sepsis — validating the model's ability to detect early physiological change before traditional thresholds are crossed.
// Traction & Validation
Grounded in real-world clinical evidence.
350+
Patients across
clinical studies
7
Countries with active
evaluation commitments
// Research & Validation Partners
Mayo Clinic
Red de Salud UC CHRISTUS
Additional sites in active development
✓
Multiple Letters of Support from clinical institutions supporting ongoing validation
✓
Multiple Letters of Intent from clinical institutions supporting deployment
✓
NCTECH AI, ML & Data Innovation Company of the Year — 2025
✓
F6S Top 40 AI Company in the United States — 2025
This page is intended for accredited investors and institutional partners. Information contained herein may include forward-looking statements subject to risks and uncertainties. Past clinical study results do not guarantee future performance. For full investor materials, contact investors@akouohealth.com.